Back
ADMA Biologics Quote, Financials, Valuation and Earnings
Sponsored
ADMA
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
66
ADMA
ADMA Biologics
Last Price:
19.04
Seasonality Move:
3.76%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.ADMA Biologics Price Quote
$19.04
ADMA Biologics Key Stats
Buy
66
ADMA Biologics (ADMA)
is a Buy
Day range:
$19.02 - $20.34
52-week range:
$3.60 - $23.64
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.80
P/B ratio:
19.41%
Volume:
3.6M
Avg. volume:
4.7M
1-year change:
401.05%
Market cap:
$4.5B
Revenue:
$258.2M
EPS:
$0.28
How Much Does ADMA Biologics Make?
-
How Much Are ADMA Biologics's Sales Annually?
ADMA Revenues are $258.2M -
How Much Profit Does ADMA Biologics's Make A Year?
ADMA net income is -$28.2M
Is ADMA Biologics Growing As A Company?
-
What Is ADMA Biologics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.78% -
What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 14%
ADMA Biologics Stock Price Performance
-
Did ADMA Biologics Stock Go Up Last Month?
ADMA Biologics share price went up by 14.84% last month -
Did ADMA's Share Price Rise Over The Last Year?
ADMA share price rose by 401.05% over the past 1 year
What Is ADMA Biologics 52-Week High & Low?
-
What Is ADMA Biologics’s 52-Week High Share Price?
ADMA Biologics has traded as high as $23.64 over the past 52 weeks -
What Is ADMA Biologics’s 52-Week Low Share Price?
ADMA Biologics has traded as low as $3.60 over the past 52 weeks
ADMA Biologics Price To Free Cash Flow
-
Is ADMA Biologics Stock Overvalued?
ADMA Biologics is trading at a price to free cash flow ratio of 57.33 -
Is ADMA Biologics Stock Undervalued?
ADMA Biologics EV to Free Cash Flow ratio is 57.29 -
What Is ADMA Biologics’s Price Earnings Growth Ratio?
ADMA PEG ratio is 0.00 -
Is ADMA Biologics Trading At A Premium To Earnings?
ADMA Biologics EV to EBIT ratio is 49.83
Is It Risky To Buy ADMA Biologics?
-
How Much Debt Does ADMA Biologics Have?
Total long term debt quarterly is $101.3M -
How Much Cash Does ADMA Biologics Have?
Cash and short term investments quarterly total is $86.7M -
What Is ADMA Biologics’s Book Value Per Share?
Book value per share is 0.98
Is ADMA Biologics Cash Flow Positive?
-
What Is ADMA Cash Flow From Operations?
Cash flow from operations (TTM) is $86.1M -
What Is ADMA Biologics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$66.3M -
What Is ADMA Biologics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$7.2M
ADMA Biologics Return On Invested Capital
-
Is Management Doing A Good Job?
ADMA return on invested capital is 22.77% -
What Is ADMA Biologics Return On Assets?
ROA measures how assets are converting to revenues and is 18.97% -
What Is ADMA Return On Equity?
ROE is a measure of profitability and is 39.59%
ADMA Biologics Earnings Date & Stock Price
-
What Is ADMA Biologics's Stock Price Today?
A single share of ADMA can be purchased today for 19.04 -
What Is ADMA Biologics’s Stock Symbol?
ADMA Biologics trades on the nasdaq under the ticker symbol: ADMA -
When Is ADMA Biologics’s Next Earnings Date?
The next quarterly earnings date for ADMA Biologics is scheduled on February 28, 2025 -
When Is ADMA's next ex-dividend date?
ADMA Biologics's next ex-dividend date is November 17, 2024 -
How To Buy ADMA Biologics Stock?
You can buy ADMA Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ADMA Biologics Competitors
-
Who Are ADMA Biologics's Competitors?
Below is a list of companies who compete with ADMA Biologics or are related in some way:
ADMA Biologics Dividend Yield
-
What Is ADMA Dividend Yield?
ADMA Biologics’s dividend yield currently is 0% -
What Is ADMA Biologics’s Payout Ratio?
ADMA Biologics’s payout ratio is 0% -
When Did ADMA Biologics Last Pay A Dividend?
The latest dividend pay date is November 17, 2024 -
What Is ADMA Biologics’s Dividend Per Share?
ADMA Biologics pays a dividend of $0.00 per share
ADMA Biologics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 1400% | 15.39% |
Revenue: | 78.13% | 13.22% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 23.45 |
Upside from Last Price: | 23.14% |